Clinical Trial Results:
An Open-Label, Phase IIIb, Multi-Centre, Randomised, Parallel-Group Study to Investigate the Efficacy and Safety of Three Dosing Schedules of Subcutaneous Dynepo in Adult Patients with Anaemia Associated with Chronic Kidney Disease who are Pre-Dialysis or Require Peritoneal Dialysis or Haemodialysis.
Summary
|
|
EudraCT number |
2006-002052-15 |
Trial protocol |
GB BE AT FR DE IT LT LV HU |
Global completion date |
31 Jul 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
12 Jul 2018
|
First version publication date |
20 Dec 2014
|
Other versions |
|
Summary report(s) |
SPD490-301 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.